Eurus Lifesciences Llp - Due diligence report

A 360° intelligence report on Eurus Lifesciences Llp: trust score, financial health, credit view, compliance, directors, growth and distress…

2017-12-08 Ahmadabad City, Gujarat Active
Share
Connect MCP
EL Eurus Lifesciences Llp
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Eurus Lifesciences Llp — 360° Intelligence Report

Generated from MCA filings & public records
88/100
Trust Score
Low Risk

Eurus Lifesciences Llp is assessed as Low Risk with a Trust Score of 88/100. Eurus Lifesciences Llp is an active limited liability partnership incorporated in 2017, operating in the Pharma sector. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 12 Aug 2026 from the latest processed filings. Eurus Lifesciences Llp snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
88/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
100/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
75/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
70/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
75/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 4 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 70/100 Moderate
  • No open charges - unencumbered balance sheet.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 100/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
VIRAL PRAKASH SHAH 01234567 Director 01/04/2018 6 yrs Approved
ULLASBHAI MANUBHAI SHAH 01234567 Director 01/04/2018 6 yrs Approved
BHAVIK JAIN 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 75 · Distress 90
Growth signals & trust indicators
Latest year revenue grew 38%.
Profit expanded 1.42 year-on-year.
Net margin improved to 2.1x.
Operating for 8 years.
Active GST registration(s).
Distress signals & risk flags
No critical warning flags detected in the available data.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence93/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment79/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view78/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 3 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 6 events
31 Mar 2025
Last AGM held
Annual general meeting
Latest balance sheet
Filed with ROC
08 Dec 2017
Incorporated
Registered with Roc Ahmedabad
Director appointed
VIRAL PRAKASH SHAH (Designated Partner)
Director appointed
ULLASBHAI MANUBHAI SHAH (Designated Partner)
Director appointed
BHAVIK JAIN (Designated Partner)
10

Key Observations

Auto-generated from the data above
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Signit Laboratories Pvt Ltd U14232PB1994PTC014204 Ludhiana, Punjab, India
Wytech Pharmaceuticals Private Limited U24233CH2015PTC035814 Chandigarh, Chandigarh, India
Sankalpa Human Resource Development Corporation Limited U74999PN2017PLC168945 Pune City, Maharashtra, India
Reliv Healthcare Private Limited U36999MH2017FTC292695 Mumbai, Maharashtra, India
Maximus Healthcare Private Limited U74900TN2013PTC089761 Chennai, Tamil Nadu, India
Torento Labs Limited U24297UR2020PLC010714 Roorkee, Uttarakhand, India
Leads Pharma Private Limited U24233TG2007PTC054104 Hyderabad, Telangana, India
Lucis Pharmaceutical Private Limited U24239WB2004PTC100505 Kolkata, West Bengal, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Eurus Lifesciences Llp before audits and certifications: compliance score 100/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Eurus Lifesciences Llp: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 70/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 75/100, margin trends, ownership structure and peer set for Eurus Lifesciences Llp - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 88/100, distress signals and MSME payment-delay disclosures - know whether Eurus Lifesciences Llp pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Eurus Lifesciences Llp - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Eurus Lifesciences Llp an active company?

Eurus Lifesciences Llp has MCA status “Active” with a compliance score of 100/100 (Low Risk).

Is Eurus Lifesciences Llp financially healthy?

Eurus Lifesciences Llp has a Financial Health Score of 75/100 (Low Risk) based on its filed financial statements.

Should I do business with Eurus Lifesciences Llp?

Its overall Trust Score is 88/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Eurus Lifesciences Llp?

See the directors and ownership sections above for board and shareholding detail. 3 active director(s) are on record.

Does Eurus Lifesciences Llp have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Eurus Lifesciences Llp up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 100/100 (Low Risk).

Is it risky to lend to Eurus Lifesciences Llp?

Its Credit Risk Score is 70/100 (Moderate). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.